Pentazocine Induced Fibromyositis: Mimicking as Faciosapulohumeral Dystrophy: A Case Report and Review
Chaurasia Rameshwar Nath, Patidar Surya P, and Joshi Deepika
Department of Neurology, Institute of Medical Science, Banaras Hindu University, Varanasi-221005, UP, India.
Abstract—Complications of parenteral narcotic abuse such as localized sclerosis of skin and subcutaneous tissue, indurations and nonseptic ulcerations were well documented, but fibromyositis is very rare. We are reporting an interesting case of pentazocine induced fibromyositis which presented as scapulohumeral and facial muscle weakness mimicking as FSHD. Interesting aspect of this case, which has not been frequently observed, is the involvement of muscle groups which were not injected with pentazocine. This case highlights the care that needs to be taken when prescribing opioid analgesics, such as pentazocine, as routine painkillers.
Index Terms—Pentazocine-Fascioscapulohumeral dystrophy (FSHD) - Urinary Tract Infection- Complications
Cite: Chaurasia Rameshwar Nath, Patidar Surya P, and Joshi Deepika, "Pentazocine Induced Fibromyositis: Mimicking as Faciosapulohumeral Dystrophy: A Case Report and Review," International Journal of Pharma Medicine and Biological Sciences, Vol. 1, No. 2, pp. 139-142, October 2012.
Previous paper:Prevalence of Extended Spectrum Beta-Lactamases (ESBLs) Carrying Genes in Klebsiella Spp from Clinical Samples at Ile-Ife, South Western Nigeria
Next paper:Multidrug Resistance Escherichia coli Carrying Extended-Spectrum β-Lactamases Enzymes in a Tertiary Care Hospital in Osogbo, South Western Nigeria
Next paper:Multidrug Resistance Escherichia coli Carrying Extended-Spectrum β-Lactamases Enzymes in a Tertiary Care Hospital in Osogbo, South Western Nigeria